UPDATED Sep 30, 2025
Discover U.S. Pharmaceuticals & Biotech Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
SONN | US$4.58 | -26.2% | -17.1% | US$31.3m | US$20.00 | PS31.3x | n/a | n/a | ||
IBIO | US$0.83 | 3.8% | -64.3% | US$16.3m | US$4.20 | PS40.7x | S-171.5% | n/a | ||
YDES | US$19.47 | -7.5% | 72.9% | US$1.3b | n/a | PS2682.7x | n/a | n/a | ||
ADTX | US$0.75 | -26.3% | -99.9% | US$4.1m | n/a | PS310.6x | n/a | n/a | ||
EXOZ | US$14.43 | -1.2% | n/a | US$121.6m | n/a | PB16.7x | n/a | n/a | ||
TRAW | US$1.85 | -1.6% | -66.8% | US$13.4m | n/a | PS4.5x | n/a | n/a | ||
THAR | US$2.84 | 0.7% | 18.3% | US$16.0m | n/a | PB42.6x | n/a | n/a | ||
BYSI | US$1.81 | 9.0% | -24.9% | US$73.0m | n/a | PE-8.9x | n/a | n/a | ||
KLTO | US$0.48 | -6.7% | -23.3% | US$29.7m | n/a | PB2.8x | n/a | n/a | ||
RENB | US$1.42 | -17.7% | -69.1% | US$29.2m | n/a | PE-0.2x | n/a | n/a | ||
CYCN | US$2.30 | -23.8% | -8.7% | US$7.5m | n/a | PS3.4x | n/a | n/a | ||
PLUR | US$4.48 | -3.7% | -16.1% | US$37.6m | US$12.00 | PS27.3x | S94.2% | n/a | ||
BGM | US$10.24 | -12.9% | n/a | US$1.8b | n/a | n/a | n/a | n/a | ||
NSRX | US$6.65 | -17.0% | n/a | US$68.4m | US$22.00 | PE-38.8x | S78.0% | n/a | ||
LIXT | US$5.03 | -5.8% | 166.1% | US$22.9m | n/a | PB35.2x | n/a | n/a |